Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





New Guidance on Managing COVID-19 Patient Airways to Help Improve Outcome of Respiratory Support and Treatment

By HospiMedica International staff writers
Posted on 03 Dec 2020
As the coronavirus pandemic continues and the knowledge about it evolves, a team of researchers has worked to form a consensus on properly managing COVID-19 patient airways.

Since COVID-19 acutely affects the respiratory system, airway management is a significant concern among patients. More...
However, because the virus is new and knowledge about it evolves, clear guidance on best practices remains hard to come by, especially on the topic of airway management. An international research group of experts led by a faculty member at the Perelman School of Medicine of the University of Pennsylvania (Philadelphia, PA, USA) has published an international expert consensus to better facilitate patient treatment amid the pandemic. With enough evidence from experts across the medical field, the experts were able to form a tentative consensus on the use of high-flow nasal oxygen and when tracheal intubation is best performed.

Initial guidelines had actually discouraged the use of high-flow nasal oxygen due to fears of the potential for aerosolization of the virus and infection of health care workers. However, there was no clear evidence that demonstrated using high-flow nasal oxygen increased the likelihood of COVID-19 transmission to health care workers. Since recent studies suggested its benefit to improve outcomes in COVID-19 patients, the experts have recommended that clinicians follow their standard benefit/risk ratio assessment for the care of the patient, themselves. This recommendation comes along with the provision that physicians use as high a level of PPE as possible.

The experts have also suggested guidelines on the timing of tracheal intubation, attempting to parse whether “early” or “late” intubation was better for patients. Some of the studies reviewed by them showed benefits to early intubation, before the disease progressed too much and when it was less hazardous for health care workers. However, there really hasn’t been a consensus, so the experts determined that individual patient conditions should be the main governing factor. Moving forward, as more is discovered about COVID-19, the experts plan to update their guidance.

“We hope that through our work to put this together, health systems will take note and the overall outcome of respiratory support and treatment in COVID-19 patients will improve,” said the lead author Huafeng Wei, MD, PhD, an associate professor of Anesthesiology at Penn Medicine. “We also hope this work will help guide health care workers toward working more safely.”

Related Links:
University of Pennsylvania


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.